Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
2,107
Value
$171.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ARWR by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,107$171.7K<0.1%+1,103+109.9%AddedHolders
Q1 20261,004$63.0K<0.1%+806+407.1%AddedHolders
Q4 2025198$13.1K<0.1%+41+26.1%AddedHolders
Q3 2025157$5.42K<0.1%−57−26.6%ReducedHolders
Q2 2025214$3.38K<0.1%+155+262.7%AddedHolders
Q1 202559$752<0.1%−1,074−94.8%ReducedHolders
Q4 20241,133$21.3K<0.1%+917+424.5%AddedHolders
Q3 2024216$4.18K<0.1%+61+39.4%AddedHolders
Q2 2024155$4.03K<0.1%−438−73.9%ReducedHolders
Q1 2024593$17.0K<0.1%+47+8.6%AddedHolders
Q4 2023546$16.7K<0.1%+546NewHolders
Q3 20230$00.0%−17−100.0%Sold outHolders
Q2 202317$606<0.1%−37−68.5%ReducedHolders
Q1 202354$1.37K<0.1%−910−94.4%ReducedHolders
Q4 2022964$39.1K<0.1%+165+20.7%AddedHolders
Q3 2022799$26.0K<0.1%+18+2.3%AddedHolders
Q2 2022781$27.0K<0.1%+75+10.6%AddedHolders
Q1 2022706$32.0K<0.1%−113−13.8%ReducedHolders
Q4 2021819$54.0K<0.1%+722+744.3%AddedHolders
Q3 202197$6.00K<0.1%−144−59.8%ReducedHolders
Q2 2021241$20.0K<0.1%+73+43.5%AddedHolders
Q1 2021168$11.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.